» Articles » PMID: 23852582

RNA-based Tools for Nuclear Reprogramming and Lineage-conversion: Towards Clinical Applications

Overview
Publisher Springer
Date 2013 Jul 16
PMID 23852582
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The therapeutic potential of induced pluripotent stem cells (iPSCs) is well established. Safety concerns remain, however, and these have driven considerable efforts aimed at avoiding host genome alteration during the reprogramming process. At present, the tools used to generate human iPSCs include (1) DNA-based integrative and non-integrative methods and (2) DNA-free reprogramming technologies, including RNA-based approaches. Because of their combined efficiency and safety characteristics, RNA-based methods have emerged as the most promising tool for future iPSC-based regenerative medicine applications. Here, I will discuss novel recent advances in reprogramming technology, especially those utilizing the Sendai virus (SeV) and synthetic modified mRNA. In the future, these technologies may find utility in iPSC reprogramming for cellular lineage-conversion, and its subsequent use in cell-based therapies.

Citing Articles

Reprogrammed human lateral ganglionic eminence precursors generate striatal neurons and restore motor function in a rat model of Huntington's disease.

McCaughey-Chapman A, Burgers A, Combrinck C, Marriott L, Gordon D, Connor B Stem Cell Res Ther. 2024; 15(1):448.

PMID: 39578834 PMC: 11583420. DOI: 10.1186/s13287-024-04057-9.


Polymers as Efficient Non-Viral Gene Delivery Vectors: The Role of the Chemical and Physical Architecture of Macromolecules.

Khan M Polymers (Basel). 2024; 16(18).

PMID: 39339093 PMC: 11435517. DOI: 10.3390/polym16182629.


Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma.

Cantero M, Bueloni B, Gonzalez Llamazares L, Fiore E, Lameroli L, Atorrasagasti C Stem Cell Res Ther. 2024; 15(1):208.

PMID: 38992782 PMC: 11241816. DOI: 10.1186/s13287-024-03806-0.


Vascular endothelial growth factor a modified mRNA engineered cellular electrospun membrane complexes promotes mouse skin wound repair.

Ai X, Luo R, Wang H, Yan B, Li K, Yu X Mater Today Bio. 2023; 22:100776.

PMID: 37664797 PMC: 10474086. DOI: 10.1016/j.mtbio.2023.100776.


Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine.

Dhanjal D, Singh R, Sharma V, Nepovimova E, Adam V, Kuca K Curr Med Chem. 2023; 31(13):1646-1690.

PMID: 37138422 DOI: 10.2174/0929867330666230503144619.


References
1.
Murry C, Keller G . Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008; 132(4):661-80. DOI: 10.1016/j.cell.2008.02.008. View

2.
Narsinh K, Jia F, Robbins R, Kay M, Longaker M, Wu J . Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc. 2011; 6(1):78-88. PMC: 3657506. DOI: 10.1038/nprot.2010.173. View

3.
Woltjen K, Michael I, Mohseni P, Desai R, Mileikovsky M, Hamalainen R . piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009; 458(7239):766-70. PMC: 3758996. DOI: 10.1038/nature07863. View

4.
Campbell K, McWhir J, Ritchie W, Wilmut I . Sheep cloned by nuclear transfer from a cultured cell line. Nature. 1996; 380(6569):64-6. DOI: 10.1038/380064a0. View

5.
Kariko K, Buckstein M, Ni H, Weissman D . Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005; 23(2):165-75. DOI: 10.1016/j.immuni.2005.06.008. View